Daniel Teper, MBA, PHARMD

Dr. Teper is the principal founder of Cytovia Therapeutics. He established the strategic vision of the company and secured the key foundation product and technology acquisitions. Previously, Dr. Teper was the founder and CEO of Immune Pharmaceuticals, which he listed on NASDAQ. He also served as New York-based Managing Partner (Head of North America) at Bionest Partners.He was previously a Partner at ISO Healthcare Group (now Deloitte Monitor) in New York. Dr. Teper helped drive the accelerated growth of Softwatch, a pioneer digital health company.He also served as global president of Havas Health, advising on global drug launches . Dr. Teper started his career at Novartis in Basel and then in the US. Dr. Teper held general management at GlaxoSmithKline and Sanofi. He was the CEO of Wintec Pharma. and then co-founder of Novagali (EuroNext). He holds a Doctor of Pharmacy degree from ParisXI University and an MBA from INSEAD.